DrugPatentWatch Database Preview
Drugs in MeSH Category Cholinesterase Inhibitors
» See Plans and Pricing
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan | GALANTAMINE HYDROBROMIDE | galantamine hydrobromide | TABLET;ORAL | 077590-003 | May 29, 2009 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
Watson Labs | GALANTAMINE HYDROBROMIDE | galantamine hydrobromide | CAPSULE, EXTENDED RELEASE;ORAL | 079028-003 | Dec 15, 2008 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
Hikma | GALANTAMINE HYDROBROMIDE | galantamine hydrobromide | SOLUTION;ORAL | 078185-001 | Jan 30, 2009 | RX | No | Yes | Start Trial | Start Trial | Start Trial | ||||
Bausch | MESTINON | pyridostigmine bromide | INJECTABLE;INJECTION | 009830-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |